| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
1998-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2573486a6c89889a8215199d48669934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a8d14c6ded9b9ad852d4a815cf4b83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a2c61f2cca19e5947ea3341f4b300d5 |
| publicationDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-9811937-A |
| titleOfInvention |
Method of increasing the bioavailability of fexofenadine and its derivatives |
| abstract |
Invention Patent: <B> "METHOD OF INCREASING THE BIOAVAILABILITY OF FEXOFENADINE AND ITS DERIVATIVES" <D>. The present invention relates to a method of increasing the bioavailability of a piperidinoalkanol antihistamine in a patient, which comprises co-administering to said patient an effective antihistamine amount of said piperidinoalkanol and an inhibiting amount of effective p-glycoprotein from a p-glycoprotein inhibitor. |
| priorityDate |
1997-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |